RecruitingPhase 2NCT06199037
Safety and Pharmacodynamics of SHR-1707 in Alzheimer's Disease Patients
Studying NON RARE IN EUROPE: Alzheimer disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Intervention
- SHR-1707(drug)
- Enrollment
- 45 target
- Eligibility
- 50-85 years · All sexes
- Timeline
- 2024 – 2026
Study locations (1)
- The First Affiliated hospital of USTC, Hefei, Anhui, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06199037 on ClinicalTrials.govOther trials for NON RARE IN EUROPE: Alzheimer disease
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNANCT07250113WeCareToFeedDysphagia to Reduce Care-partner Burden Full-scale RCTNorthwell Health
- RECRUITINGNCT07457138Lombard Cohort of Brain Health ServicesUniversity of Milano Bicocca
- RECRUITINGNANCT07286448Personalized Digital Training for COGnitive FITness in Mild Cognitive ImpairmentGiovanna Zamboni
- ACTIVE NOT RECRUITINGNANCT07479914Art of Memory for Cognitive Enhancement in the Monza Brain Health ServiceUniversity of Milano Bicocca
- RECRUITINGNANCT07212504Effect of Accelerated Neuromodulation of Anterior Cingulate Cortex to Enhance Cognition in Older Adults With Mild Memory ProblemsRotman Research Institute at Baycrest
- ENROLLING BY INVITATIONNANCT07168824An Open Label Trial Evaluating the Efficacy of Lacticaseibacillus Paracasei PS23 on CognitionChi-Chang Huang
- ACTIVE NOT RECRUITINGNANCT07350226Electro-acupuncture for SCD With DepressionThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- RECRUITINGNCT07402161The Signature of Alzheimer's Disease in Subjective Cognitive DeclineIRCCS Policlinico S. Donato